PubRank

J S Hochman

Author PubWeight™ 63.29‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 2000 3.54
2 ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina). Circulation 2000 3.02
3 American College of Cardiology/Society for Cardiac Angiography and Interventions Clinical Expert Consensus Document on cardiac catheterization laboratory standards. A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 2001 2.09
4 Limitation of myocardial infarct expansion by reperfusion independent of myocardial salvage. Circulation 1987 1.90
5 American College of Cardiology/American Heart Association Expert Consensus document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. Circulation 2000 1.69
6 Outcome and profile of ventricular septal rupture with cardiogenic shock after myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK? J Am Coll Cardiol 2000 1.65
7 Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase. Results from GUSTO-III. Global Use of Strategies to Open Occluded Coronary Arteries. Eur Heart J 1999 1.57
8 Lack of progress in cardiogenic shock: lessons from the GUSTO trials. Eur Heart J 2000 1.50
9 Acute myocardial infarction triggered by emotional stress. Am J Cardiol 1992 1.43
10 New approaches to diagnosis and management of unstable angina and non-ST-segment elevation myocardial infarction. Arch Intern Med 2001 1.42
11 First experience with direct, selective factor Xa inhibition in patients with non-ST-elevation acute coronary syndromes: results of the XaNADU-ACS Trial. J Thromb Haemost 2005 1.42
12 Effect of very early angiotensin-converting enzyme inhibition on left ventricular dilation after myocardial infarction in patients receiving thrombolysis: results of a meta-analysis of 845 patients. FAMIS, CAPTIN and CATS Investigators. J Am Coll Cardiol 2000 1.40
13 Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol 2000 1.32
14 The marijuana problem. Ann Intern Med 1970 1.27
15 Expansion of acute myocardial infarction: an experimental study. Circulation 1982 1.25
16 Early revascularization is associated with improved survival in elderly patients with acute myocardial infarction complicated by cardiogenic shock: a report from the SHOCK Trial Registry. Eur Heart J 2003 1.14
17 Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes. PURSUIT Investigators. Platelet IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin Therapy. Am J Cardiol 1999 1.10
18 Cardiogenic shock due to cardiac free-wall rupture or tamponade after acute myocardial infarction: a report from the SHOCK Trial Registry. Should we emergently revascularize occluded coronaries for cardiogenic shock? J Am Coll Cardiol 2000 1.09
19 Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib. Ann Rheum Dis 2007 1.09
20 Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists: observations from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction 9 Study. J Am Coll Cardiol 1999 1.07
21 Cardiogenic shock complicating acute myocardial infarction: predictors of death. GUSTO Investigators. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries. Am Heart J 1999 1.02
22 Pathogenesis of left ventricular aneurysms: an experimental study in the rat model. Am J Cardiol 1982 1.01
23 Percutaneous coronary intervention for cardiogenic shock in the SHOCK Trial Registry. Am Heart J 2001 1.00
24 Cardiogenic shock due to acute severe mitral regurgitation complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we use emergently revascularize Occluded Coronaries in cardiogenic shocK? J Am Coll Cardiol 2000 0.99
25 The late open artery hypothesis--a decade later. Am Heart J 2001 0.99
26 Interaction of ischaemia and encainide/flecainide treatment: a proposed mechanism for the increased mortality in CAST I. Br Heart J 1995 0.99
27 Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevation. Circulation 1999 0.95
28 Angiographic findings and clinical correlates in patients with cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol 2000 0.94
29 Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction. J Am Coll Cardiol 2000 0.94
30 Survival outcomes 1 year after reperfusion therapy with either alteplase or reteplase for acute myocardial infarction: results from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) III Trial. Circulation 2000 0.93
31 The heart in polyarteritis nodosa: a clinicopathologic study. Am Heart J 1985 0.92
32 Absence of gender differences in clinical outcomes in patients with cardiogenic shock complicating acute myocardial infarction. A report from the SHOCK Trial Registry. J Am Coll Cardiol 2001 0.92
33 Implications of the timing of onset of cardiogenic shock after acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol 2000 0.91
34 Serum estrogen levels in men with acute myocardial infarction. Am J Med 1982 0.88
35 Effects of prior aspirin and anti-ischemic therapy on outcome of patients with unstable angina. TIMI 7 Investigators. Thrombin Inhibition in Myocardial Ischemia. Am J Cardiol 1998 0.88
36 Successful repair of myocardial free wall rupture after thrombolytic therapy for acute infarction. Ann Thorac Surg 2000 0.87
37 Platelet glycoprotein IIb/IIIa blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST-segment elevation. J Am Coll Cardiol 2000 0.85
38 The clinical profile of patients with suspected cardiogenic shock due to predominant left ventricular failure: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK? J Am Coll Cardiol 2000 0.84
39 Atrial fibrillation and mortality among patients with acute coronary syndromes without ST-segment elevation: results from the PURSUIT trial. Am J Cardiol 2001 0.84
40 Genetic testing in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a cost-effectiveness analysis. J Thromb Haemost 2013 0.83
41 Effects of thrombolytic therapy administered 6 to 24 hours after myocardial infarction on the signal-averaged ECG. Results of a multicenter randomized trial. LATE Ancillary Study Investigators. Late Assessment of Thrombolytic Efficacy. Circulation 1994 0.83
42 Chronic marihuana usage and liver function. Lancet 1971 0.82
43 Aortic counterpulsation in acute myocardial infarction: physiologically important but does the patient benefit? Am Heart J 2001 0.81
44 Early reperfusion, late reperfusion, and the open artery hypothesis: an overview. Prog Cardiovasc Dis 2000 0.81
45 The use of intraaortic balloon counterpulsation as an adjunct to reperfusion therapy in cardiogenic shock. Int J Cardiol 1998 0.81
46 Effect of exercise on acute myocardial infarction in rats. J Am Coll Cardiol 1986 0.80
47 Management of patients with acute coronary syndromes in the United States by platelet glycoprotein IIb/IIIa inhibition. Insights from the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial. Circulation 2000 0.80
48 Chronic marijuana use and psychosocial adaptation. Am J Psychiatry 1973 0.79
49 New heparin dosing recommendations for patients with acute coronary syndromes. Am J Med 2001 0.78
50 Acute myocardial infarction complicated by systemic hypoperfusion without hypotension: report of the SHOCK trial registry. Am J Med 2000 0.78
51 Diabetes mellitus in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol 2000 0.77
52 Functional consequences of acute collagen degradation studied in crystalloid perfused rat hearts. Basic Res Cardiol 1997 0.77
53 Cardiogenic shock with non-ST-segment elevation myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded coronaries for Cardiogenic shocK? J Am Coll Cardiol 2000 0.77
54 Initial experience with factor-Xa inhibition in percutaneous coronary intervention: the XaNADU-PCI Pilot. J Thromb Haemost 2004 0.76
55 Comparison of benefits and complications of hirudin versus heparin for patients with acute coronary syndromes undergoing early percutaneous coronary intervention. Am J Cardiol 2001 0.76
56 Marijuana intoxication: pharmacological and psychological factors. Dis Nerv Syst 1971 0.75
57 Has the time come to seek and open all occluded infarct-related arteries after myocardial infarction? J Am Coll Cardiol 1996 0.75
58 Relation between infarct artery patency at late angiography after acute myocardial infarction and signal-averaged electrocardiography. Am J Cardiol 1999 0.75
59 Reference guide to cardiogenic shock complicating acute myocardial infarction. J Thromb Thrombolysis 2000 0.75
60 Endocardial abnormalities in left ventricular aneurysms. A clinicopathologic study. Ann Intern Med 1984 0.75
61 Current patterns of drug misuse. Calif Med 1972 0.75
62 Indications for immediate angiotensin-converting enzyme inhibition in patients with acute myocardial infarction. J Am Coll Cardiol 1995 0.75